Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax

Clinical trial NCT05092373 · RECRUITING

Trial details

NCT number: NCT05092373
Sponsor: M.D. Anderson Cancer Center
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Breast Carcinoma Advanced Endometrial Carcinoma Advanced Fallopian Tube Carcinoma Advanced Hepatocellular Carcinoma Advanced Malignant Abdominal Neoplasm Advanced Malignant Female Reproductive System Neoplasm Advanced Malignant Thoracic Neoplasm Advanced Ovarian Carcinoma Advanced Primary Peritoneal Carcinoma Advanced Renal Cell Carcinoma Anatomic Stage III Breast Cancer AJCC v8 Anatomic Stage IIIA Breast Cancer AJCC v8

Start date: 2022-04-29
Primary completion: 2026-09-01
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.